FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
WeissLaw LLP Investigates Bioverativ Inc. Acquisition PR Newswire NEW YORK, Jan. 24, 2018 NEW YORK, Jan. 24, 2018 /PRNewswire/ -- WeissLaw LLP is...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
By Jonathan D. Rockoff This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S...
By Jonathan D. Rockoff Big drugmakers, searching for new sources of revenue, are paying hefty premiums for biotechnology businesses, with two...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
By Jonathan D. Rockoff A pair of multibillion-dollar biotech deals announced Monday commanded hefty premiums, driven by big drugmakers' need...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.